UK markets open in 3 hours

Physicians Realty Trust (DOC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
18.88+0.27 (+1.45%)
At close: 04:00PM EDT
18.99 +0.11 (+0.58%)
After hours: 07:31PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.10B
Enterprise value 22.06B
Trailing P/E 53.17
Forward P/E 103.09
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.61
Price/book (mrq)1.47
Enterprise value/revenue 9.75
Enterprise value/EBITDA 18.27

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-11.69%
S&P500 52-week change 323.57%
52-week high 322.38
52-week low 315.24
50-day moving average 317.83
200-day moving average 318.63

Share statistics

Avg vol (3-month) 37.91M
Avg vol (10-day) 35.95M
Shares outstanding 5703.78M
Implied shares outstanding 6703.78M
Float 8700.15M
% held by insiders 10.29%
% held by institutions 176.92%
Shares short (15 Apr 2024) 410.62M
Short ratio (15 Apr 2024) 41.71
Short % of float (15 Apr 2024) 41.89%
Short % of shares outstanding (15 Apr 2024) 41.50%
Shares short (prior month 15 Mar 2024) 49.7M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 46.36%
Trailing annual dividend rate 31.20
Trailing annual dividend yield 36.45%
5-year average dividend yield 44.93
Payout ratio 4342.86%
Dividend date 317 May 2024
Ex-dividend date 403 May 2024
Last split factor 21098:1000
Last split date 301 Nov 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.56%
Operating margin (ttm)3.78%

Management effectiveness

Return on assets (ttm)1.22%
Return on equity (ttm)2.51%

Income statement

Revenue (ttm)2.26B
Revenue per share (ttm)4.03
Quarterly revenue growth (yoy)15.40%
Gross profit (ttm)N/A
EBITDA 1.12B
Net income avi to common (ttm)193.06M
Diluted EPS (ttm)0.35
Quarterly earnings growth (yoy)-94.40%

Balance sheet

Total cash (mrq)149.2M
Total cash per share (mrq)0.21
Total debt (mrq)9.06B
Total debt/equity (mrq)94.41%
Current ratio (mrq)2.25
Book value per share (mrq)12.62

Cash flow statement

Operating cash flow (ttm)934.88M
Levered free cash flow (ttm)617.34M